AVANOS MEDICAL, INC.: net property, plant and equipment
Net property, plant and equipment for AVANOS MEDICAL, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All AVANOS MEDICAL, INC. financial histories
What this measure means
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
Exact concept: us-gaap:PropertyPlantAndEquipmentNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2013-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 113,400,000 | USD | 2026-02-24 | 10-K · 0001606498-26-000004 |
| At date | 2024-12-31 | 110,700,000 | USD | 2026-02-24 | 10-K · 0001606498-26-000004 |
| At date | 2023-12-31 | 117,200,000 | USD | 2025-02-26 | 10-K · 0001606498-25-000024 |
| At date | 2022-12-31 | 118,600,000 | USD | 2024-02-21 | 10-K · 0001606498-24-000018 |
| At date | 2021-12-31 | 168,100,000 | USD | 2023-02-21 | 10-K · 0001606498-23-000020 |
| At date | 2020-12-31 | 175,300,000 | USD | 2022-02-23 | 10-K · 0001606498-22-000029 |
| At date | 2019-12-31 | 184,500,000 | USD | 2021-02-19 | 10-K · 0001606498-21-000015 |
| At date | 2018-12-31 | 154,100,000 | USD | 2020-02-25 | 10-K · 0001606498-20-000018 |
| At date | 2017-12-31 | 109,900,000 | USD | 2019-02-26 | 10-K · 0001606498-19-000018 |
| At date | 2016-12-31 | 109,300,000 | USD | 2018-02-27 | 10-K · 0001606498-18-000016 |
| At date | 2015-12-31 | 279,500,000 | USD | 2017-02-27 | 10-K · 0001606498-17-000008 |
| At date | 2014-12-31 | 277,800,000 | USD | 2016-02-29 | 10-K · 0001606498-16-000044 |
| At date | 2013-12-31 | 324,900,000 | USD | 2015-03-13 | 10-K · 0001606498-15-000009 |
Related financial histories
- AVANOS MEDICAL, INC.: total assets
- AVANOS MEDICAL, INC.: total liabilities
- AVANOS MEDICAL, INC.: stockholders equity
- AVANOS MEDICAL, INC.: cash and cash equivalents
- AVANOS MEDICAL, INC.: net income or loss
- AVANOS MEDICAL, INC.: operating cash flow
- AVANOS MEDICAL, INC.: contract revenue excluding tax
- AVANOS MEDICAL, INC.: financing cash flow
- AVANOS MEDICAL, INC.: investing cash flow
- AVANOS MEDICAL, INC.: retained earnings or deficit
- AVANOS MEDICAL, INC.: basic weighted-average shares
- AVANOS MEDICAL, INC.: diluted weighted-average shares
- AVANOS MEDICAL, INC.: basic earnings per share
- AVANOS MEDICAL, INC.: diluted earnings per share
- AVANOS MEDICAL, INC.: income tax expense or benefit
- AVANOS MEDICAL, INC.: share-based compensation expense
- AVANOS MEDICAL, INC.: operating income or loss
- AVANOS MEDICAL, INC.: current assets
- AVANOS MEDICAL, INC.: interest expense
- AVANOS MEDICAL, INC.: current liabilities
- AVANOS MEDICAL, INC.: current accounts payable
- AVANOS MEDICAL, INC.: goodwill carrying amount
- AVANOS MEDICAL, INC.: net finite-lived intangible assets
- AVANOS MEDICAL, INC.: net current accounts receivable
- AVANOS MEDICAL, INC.: common-stock repurchase payments
- AVANOS MEDICAL, INC.: net inventory
- AVANOS MEDICAL, INC.: gross profit
- AVANOS MEDICAL, INC.: selling, general and administrative expense
- AVANOS MEDICAL, INC.: research and development expense
Inspect the source
- Entity
- AVANOS MEDICAL, INC. / CIK 0001606498
- Captured
- 2026-09-21T17:21:16.254Z
- SEC response SHA-256
d33560654b7d20276f72b2d21b96213113dca28656a34615203ec752031122ca
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001606498.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))